One Biosciences has announced a €15 million Series A financing led by Redmile Group and Blast, with participation from Galion.exe, Invus, Adamed Technology, Sofinnova Partners, Polytechnique Ventures, and Kima Ventures.
Arca BioLogistics, a specialist in Life Science logistics, has recently concluded on a development update of its logistics management portal Arca Live.
Xeltis has announced encouraging preliminary data for Xabg, its coronary artery bypass conduit (CABG), demonstrating positive safety and patency among patients with multi-vessel atherosclerotic coronary artery disease.
The UK government has announced a new Life Sciences Sector Plan aimed at strengthening the economy and modernising the NHS, marking a significant step in its wider Industrial Strategy.
Qureight, a techbio company accelerating drug development using its proprietary deep-learning image biomarkers and clinical data analytics platform, has announced the first results from a collaboration with Insilico Medicine.
Antares Vision Group has announced a strategic partnership with LedgerDomain, a specialist in secure digital identity and credentialing for the healthcare supply chain.
For too long, regulatory teams have become bogged down by protracted reviews of the regulatory implications. Generative AI (GenAI) promises to change all that, say independent consultant Preeya Beczek and Agnes Cwienczek of ArisGlobal.
PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and supported with significant reinvestment by Mubadala Investment Company.
PSI CRO explores solid site relationships and how they are the backbone of successful clinical trials. Without happy, supported sites, enrolment simply cannot happen predictably or within budgetary constraints.
